Medical application: This study will seek to determine the utility of rigid external pelvic
immobilization in patients who are set up using real-time, state-of-the-art motion tracking
of the prostate. External immobilization devices have been criticized for being expensive,
uncomfortable, time-consuming to make, occupying a lot of space in the treatment area,
creating difficulties at the time of CT simulation, challenging for obese patients and
obscuring skin marks that can help confirm patient set up. Omitting these devices (if found
to be unnecessary) would potentially decrease treatment costs, improve patient comfort
during treatment, and reduce overall treatment time. In high risk patients, gaining a better
understanding of lymph node positioning relative to Calypso immobilization may allow for
decreased PTV margins and therefore decreased normal tissue irradiated during radiation
therapy.
Objective(s) of the investigation: This study will look at the efficacy of external pelvic
immobilization in definitive radiation therapy of prostate cancer using a unique organ
tracking system.
A. Primary Objective: To determine if rigid external pelvic immobilization demonstrates a
reduction in positioning errors. This will be assessed by determining the median, mean and
range of shifts performed in all 3 dimensions as part of initial isocenter set-up and during
treatment using the Calypso system.
B. Secondary Objectives: The study will determine the simulation time, set up time,
treatment time, total time and number of treatment interventions (repositioning/pausing)
caused by organ/target motion beyond planning target volume (PTV) margin using real time
localization. In the subset of high-risk patients, this study will assess positioning of
the lymph node target using the combination of rigid external pelvic immobilization and the
Calypso system.
Observational
Observational Model: Cohort, Time Perspective: Prospective
Rigid external pelvic immobilization demonstrates a reduction in positioning errors.
This will be assessed by determining the median, mean and range of shifts performed in all 3 dimensions as part of initial isocenter set-up and during treatment using the Calypso system.
Measured at every treatment fraction for a total of approximately 8.5 weeks
No
Dusten Macdonald, MD
Principal Investigator
Department of the Army
United States: Federal Government
W81XWH-08-2-0174, A-15214.1b
NCT01588938
December 2009
September 2014
Name | Location |
---|---|
Madigan Healthcare System | Tacoma, Washington 98431 |